会议通知

为进一步深化上海交通大学与德国慕尼黑工业大学的战略合作，推动前沿领域的学术交流与协同创新，由两校共同举办的“Future Health and Transformative Medicine in the AI Era”（人工智能时代的未来健康与转化医药）联合学术研讨会，将于2026年4月7日在上海交通大学闵行校区溥渊未来技术学院举行。

本次研讨会将汇聚慕尼黑工业大学、上海交通大学溥渊未来技术学院及上海交通大学医学院的知名学者，围绕转化医学、胰腺癌、胃癌、免疫学、细胞疗法等相关研究方向，共同探讨人工智能赋能医学发展的前沿课题。

欢迎相关研究领域的专家学者积极参会交流。如有参会意向，请与医学院国际交流处联系。

附件：1. 会议议程（草案）

     2. 慕尼黑工业大学参会教授简介

     3. 溥渊未来技术学院参会教授（拟邀）简介

上海交通大学医学院国际交流处

2026年3月20日

（联系人：罗兰，021-63846590*776411）

附件1 会议议程（草案）

Prof. Dr. Markus Gerhard

Medical Microbiology and Immunology

TUM School of Medicine and Health

Academic Career and Research Areas

The research work of Professor Gerhard (b. 1968) explores how pathogens interact with the host in gastrointestinal infections. Professor Gerhard’s research group investigates the mechanisms that suppress the immunoresponse of the host to allow the occurrence of infection as well as inflammatory factors involved in the development of cancer.

Professor Gerhard studied medicine in Heidelberg and Hamburg from 1988 to 1996. He earned his MD in 1996 (summa cum laude). From 1997 to 2004 he completed his medical training leading to German medical board certification in internal medicine in the Department of Internal Medicine (II. Medizinische Klinik) at Klinikum rechts der Isar. From 2004 to 2006 he worked at the Netherlands Institute for Developmental Biology in the research group of Professor Hans Clevers. From 2006 he headed a research group in the Department of Internal Medicine (II. Medizinische Klinik) at Klinikum rechts der Isar, where he also acquired his postdoctoral teaching qualification (habilitation) in internal medicine in 2009. In 2010 he was appointed associate professor of medical microbiology and immunology at the Institute for Medical Microbiology and Immunology, a unit within TUM. He is Academic Director of the TUM Venture Labs Healthcare.

Prof. Dr. Li Deng

Prevention of Microbial Infectious Diseases

TUM School of Life Sciences

Academic Career and Research Areas

Prof. Deng conducts research in the area of phage biology, virome and microbiome. She uses single-cell technologies, multi-omics, culture-independent techniques, and machine learning to understand the underlying mechanisms of phage-bacterial interactions and their impact on the human host. Her group develops phage-based novel therapeutics and prevention interventions for target eliminating pathogenic bacteria and ameliorating disease severity by restoring healthy microbiota in multiple diseases or conditions.

Prof. Deng studied Environmental Engineering at the Tsinghua University, China (BEng), Environmental Science at the University of Nottingham, UK (MSc) and Microbiology at the University of Bristol, UK (PhD). After her post-doctoral training at the University of Arizona, US, she joined Helmholtz Munich as the head of DFG Emmy Noether Junior group and Helmholtz Young Investigator group. She became chair professor for Prevention of Bacterial Diseases at TUM in 2022, and joint director of the Central Institute of Infection Prevention (ZIP) in 2023.

Prof. Dr. Dirk Busch

Medical Microbiology, Immunology and Hygiene

TUM School of Medicine and Health

Academic Career and Research Areas

Professor Busch (b. 1966) conducts research into infection immunology with the goal of identifying therapeutically useful defense mechanisms. His work centers on antigen-specific T cells and the development of new technologies to make immune cells usable for diagnostic and cell therapy applications.

After studying medicine in Mainz and Freiburg (1993) and completing his doctorate (1993), Professor Busch commenced his clinical infectiological training in pediatrics (Würzburg, 1993-1996). He subsequently went to Yale University supported by a DFG scholarship (1996-1999). Having qualified as a lecturer in 2003, Professor Busch completed his residency in medical microbiology and epidemiology of infection (2005) at TUM. He heads the focus group “Clinical Cell Processing and Purification” at the TUM Institute for Anvanced study and co-initiated two sucessful start-ups (STAGE cell therapeutics GmbH and T Cell Factory B.V.). Prof. Busch is Chairman of the Board of the German Center for Infection Research (DZIF) and a member of the National Academy of Sciences Leopoldina. Since 2009, he has been Director of the Institute of Medical Microbiology, Immunology and Hygiene at TUM.

Prof. Dr. Matthias Hebrok

Applied Stem Cell and Organoid Systems

TUM School of Medicine and Health

Academic Career and Research Areas

Matthias Hebrok studied biology at the University of Freiburg. Following his doctoral studies at the Max Planck Institute of Immunobiology, he conducted post-doctoral research at Harvard University, USA, with a Howard Hughes Medical Institute fellowship. He then accepted a professorship at the University of California San Francisco, where he led the Diabetes Center from 2010 until 2020.

Prof. Hebrok is director of the new TUM Center for Organoid Systems and also heads the Institute for Diabetes and Organoid Technology at Helmholtz Munich. He works on the differentiation of human stem cells into functional pancreatic organoids. Using gene editing strategies, hormone-producing islet cells are developed for cell replacement therapies for patients with diabetes. His group also generates human organoid models to explore new diagnostics and therapies for pancreatic cancer.

Prof. Dr. Maximilian Reichert

Translational pancreatic cancer research

TUM School of Medicine and Health

Awards

Elected expert of UNCAN (“A European initiative to UNderstand CANcer”) (2023)

Prix Forcheurs Jean-Marie Lehn Inauguration Award, German and French Academy of Sciences (2017)

Max-Eder Group Leader Fellowship of the German Cancer Aid (Deutsche Krebshilfe e.V.) (2015)

Scholar-in-Training Award by the American Association of Cancer Research (AACR), USA (2014)

Recipient of the Postdoctoral Fellowship of the National Pancreas Foundation (NPF), USA (2009)

Prof. Dr. Daniel Roth

Machine Intelligence in Orthopedics

TUM School of Medicine and Health

Academic Career and Research Areas

Daniel Roth's (*1985) research focuses on human-machine interfaces for medicine and health. Machine intelligence describes a holistic view of the way humans and machines communicate. A large part of his work deals with AI as well as virtual, mixed, and augmented reality-based technologies. Examples include assistance systems for surgical procedures, systems for the assessment and diagnosis of diseases and disorders, and (robot-assisted) rehabilitation.

In September 2023, Prof. Roth was appointed to the professorship for Machine Intelligence in Orthopedics at TUM and works at the School of Medicine and Health at the Klinikum rechts der Isar.Previously, he was Junior Professor for Human-Centered Computing and Extended Reality at the Department of Artificial Intelligence in Biomedical Engineering at FAU Erlangen-Nuremberg. He studied Media and Imaging Technology at the TH Cologne and subsequently completed his doctorate in computer science at the Julius-Maximilians-Universität Würzburg.

附件3 溥渊未来技术学院参会教授（拟邀）简介